Sloy Dahl & Holst, LLC Invitae Corp Transaction History

Sloy Dahl & Holst, LLC

  • $551 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 03, 2021
SELL
$24.31 - $33.6 $3.15 Million - $4.35 Million
-129,408 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$26.09 - $40.4 $92,358 - $143,016
-3,540 Reduced 2.66%
129,408 $4.36 Million
Q1 2021

May 12, 2021
BUY
$33.06 - $56.93 $4.4 Million - $7.57 Million
132,948 New
132,948 $5.08 Million

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Sloy Dahl & Holst, LLC Portfolio

Follow Sloy Dahl & Holst, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sloy Dahl & Holst, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sloy Dahl & Holst, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email